Clinical trial
APC-231 Once a Day (QD) for 7 Days vs. Penicillin Taken Four Times a Day (QID)…
NCT00100126 · Advancis Pharmaceutical Corporation, Industry · Completed
Key facts
| NCT number | NCT00100126 |
|---|---|
| Title | APC-231 Once a Day (QD) for 7 Days vs. Penicillin Taken Four Times a Day (QID) in Pediatric Patients With Strep Throat |
| Official title | A Phase III, Investigator Blind, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of APC-231 Sprinkle QD for 7 Days vs Penicillin VK 10 mg/kg QID for 10 Days in Pediatric Patients With Streptococcus Pyogenes |
| Lead sponsor | Advancis Pharmaceutical Corporation, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pharyngitis |
| Intervention type | Drug |
| Interventions | Amoxicillin Pulsatile Release Multiparticluate Sprinkle |
| Enrollment | 500 |
| Start date | Dec 1, 2004 |
| Completion | Jun 1, 2005 |
| First posted | Dec 24, 2004 |
| Last update posted | Oct 25, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: